Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F23%3A10000982" target="_blank" >RIV/00064190:_____/23:10000982 - isvavai.cz</a>

Alternative codes found

RIV/00064190:_____/22:N0000044 RIV/00216208:11110/23:10447805

Result on the web

<a href="https://doi.org/10.1111/all.15513" target="_blank" >https://doi.org/10.1111/all.15513</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/all.15513" target="_blank" >10.1111/all.15513</a>

Result language

angličtina

Original language name

Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma

Original language description

To the Editor,Asthma is a heterogeneous disease, as reflected by differences in age of onset, severity, treatment response and inflammatory profile. Matrix metalloprotease (MMP)-12 has been associated with inflammation in various subtypes of asthma. In allergic asthma, MMP-12 activity has been implicated in the accumulation of neutrophils and eosinophils, in regulating macrophage functions and in the development of airway hyperresponsiveness (AHR).

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30225 - Allergy

Project

—

Continuities

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year

2023

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

ALLERGY

ISSN

0105-4538

e-ISSN

—

Volume of the periodical

78

Issue of the periodical within the volume

2

Country of publishing house

US - UNITED STATES

Number of pages

4

Pages from-to

559-562

UT code for WoS article

000854878600001

EID of the result in the Scopus database

2-s2.0-85138154475